SIBO Explained: Symptoms, Causes, and How to Heal

Woman clutches her abdomen experiencing uncomfortable symptoms of small intestinal bacterial overgrowth, or SIBO

Summary

Could gut health hold the key? Test, don't guess. Learn more
Could gut health hold the key? Test, don't guess. Learn more

You've done everything right: timed your meals, taken post-dinner walks, filled your plate with nutritious foods, and even resisted the tempting donuts in the pantry. So why are you still bloated, gassy, and nauseous?

You might be dealing with a condition called SIBO, or small intestinal bacterial overgrowth.

In this guide, we’ll discuss SIBO, its symptoms, causes, and how to manage it. If you’re looking to regain control of your gut health, you’ve come to the right place.

What is SIBO, and why does it matter?

Your body contains trillions of bacteria, and most of these reside in the large intestine or colon. In a healthy gut, the small intestine has far fewer bacteria [1]. 

SIBO occurs when bacteria, usually found in the colon, grow in large numbers in the small intestine. When these bacteria digest carbohydrates from food, they produce gas, causing uncomfortable symptoms. 

Common SIBO symptoms:

  • Bloating or feeling overly full (especially after eating)
  • Stomach cramps or discomfort
  • Difficulty passing stools, constipation, or infrequent bowel movements
  • Excess gas, leading to burping or flatulence
  • Loose or watery stools, sometimes alternating with constipation [2]

SIBO affects up to 13% to 35% of otherwise healthy people [3]. It is often underdiagnosed and could be a root cause for those who present with conditions such as Irritable Bowel Syndrome (IBS) and inflammatory bowel disease (IBD) [4],[5].

SIBO vs. IMO

When SIBO symptoms are coupled with high levels of a microbe named Methanobrevibacter smithii, it may indicate a related condition, intestinal methanogen overgrowth (IMO) [6]. 

While SIBO is bacterial overgrowth in the small intestine, IMO involves the overgrowth of methane-producing microbes in any part of the digestive tract. Some practitioners refer to IMO as methanogenic SIBO. 

Both conditions can be hard to diagnose because their symptoms—like bloating, constipation, and abdominal discomfort—overlap with other gut issues, such as food intolerances, irritable bowel syndrome (IBS), or celiac disease.

What causes SIBO?

Your gut has natural defenses against bacterial overgrowth—think of it as a security system. This includes gastric acid and bile, which break down harmful bacteria, along with proteolytic enzymes that digest unwanted invaders. Peristalsis—your gut's natural "wave-like motion"—keeps things moving, while secretory IgA acts like a first-line antibody defense. Finally, the ileocecal valve ensures bacteria from the colon don’t backtrack into the small intestine [7].

When the system fails, problems arise. Now let’s dive in further to the main SIBO causes.

Poor gut motility (gastroparesis)

Your stomach and intestinal muscles naturally work together to push food through the digestive tract. In gastroparesis, these muscles weaken and slow down, causing food to move too slowly, creating an opportunity for bacteria to grow [8]. In other words, poor gut motility can lead to SIBO. 

Drugs that reduce gut motility may also increase SIBO risk. These include:

Stress also reduces gut motility [12], and anything that causes food to linger in the small intestine has the potential to encourage bacterial overgrowth [13]. Once SIBO develops, it can worsen nutrient deficiencies and increase inflammation, which may intensify mental health symptoms, creating a vicious cycle. 

Underlying chronic conditions

Certain pre-existing health conditions can increase the risk of SIBO by affecting gut motility, digestion, or bacterial balance. 

You’re more likely to develop SIBO if you also have:

  • Celiac disease [14]
  • Crohn’s disease [15]
  • Diabetes [16]
  • Hypothyroidism [17]
  • IBS [18]
  • Liver cirrhosis [19]
  • Obesity [20]
  • Pancreatitis [21]
  • Scleroderma [22]

Low stomach acid 

While stomach acid often gets a bad rap, it’s actually very important for your health. It breaks down food, activates enzymes that turn proteins into amino acids and kills unfriendly bacteria that could make you ill. Low stomach acid, or hypochlorhydria, can be a major problem as it impairs digestion and reduces your body’s ability to moderate bacterial growth. 

A common reason your stomach acid could be low is taking antacids or Proton Pump Inhibitors (PPIs) [23]. These medications reduce your stomach acid, which normally helps control bacterial growth, and this can contribute to SIBO. 

Helicobacter pylori infection also increases the odds of developing SIBO, because H. pylori reduces the amount of acid your stomach makes [24].

Finally, having gastric bypass surgery can also affect your stomach acid production. SIBO develops in 29% of patients within three years of gastric bypass surgery [25]. In addition, intestinal surgeries can create "blind loops" where bacteria stagnate and grow [7]. 

Long-term effects of SIBO:

SIBO doesn’t just affect your gut—it can lead to nutrient deficiencies, chronic discomfort, and even systemic health problems. 

In fact, SIBO can cause poor absorption of essential nutrients, like proteins, carbohydrates, and essential fatty acids [26]. This may lead to long-term health issues, such as: 

  • Low iron and vitamin B12 levels which often lead to weakness, weight loss, or anemia [26].
  • A damaged gut lining (leaky gut) which can allow harmful substances into the bloodstream, triggering inflammation [27].
  • Brain fog, mood swings, and worsened mood disorders like anxiety and depression [28].
  • Skin issues, such as acne, rosacea, and psoriasis [29],[30],[31].

Bottom line, if you’re experiencing symptoms of SIBO, talk to your healthcare provider. Taking action now can reduce the likelihood of future health conditions.

How is SIBO diagnosed?

If you’ve been dealing with chronic bloating, irregular bowel movements, or unexplained digestive discomfort, it might be time to explore SIBO tests with your practitioner.

Breath testing

A breath test is a simple, non-invasive test that measures hydrogen or methane gas levels in your breath after you consume a sugar solution (like glucose or lactulose) [32]. When bacteria in your small intestine ferment these sugars, they produce gases that enter your bloodstream and are exhaled. 

The glucose breath test is ideal for detecting overgrowth in the upper small intestine, where SIBO often begins [33]. A Lactulose test is useful for identifying overgrowth throughout the small intestine, though it carries a higher risk of false positives [34]. Talk to your practitioner about which test is right for you.

How breath testing works

Before taking a breath test, you’ll need to follow guidelines from your practitioner to prepare so the results are as accurate as possible. According to Cleveland Clinic, the preparation starts weeks before the test [35]:

  • One month before: Stop taking antibiotics and probiotics.
  • One week before: Stop taking laxatives, fiber supplements, antacids, and prokinetics.
  • One day before: Limit your diet to only low-fiber, easily digested foods such as baked or boiled fish or poultry with salt and pepper. Your practitioner will typically recommend you avoid oils, fats, sweeteners, seasonings, dairy, and grains (except white bread and white rice). A strict diet without fermentable foods is crucial [36].
  • Day of the test: No food or water for 12 hours. You’ll be asked to avoid exercising or sleeping within a few hours of the test.

The test itself usually takes 2 to 3 hours. Here’s what to expect:

  1. Your practitioner will collect a baseline breath sample.
  2. You’ll drink a special sugary drink (a solution of glucose, lactulose, or xylose—sugars that gut bacteria ferment). 
  3. Your practitioner takes samples of your breath periodically.
  4. The samples are analyzed for the presence of hydrogen and methane.

What the results mean: hydrogen vs. methane

During your breath test, a rise in hydrogen or methane indicates bacterial overgrowth.

  • Hydrogen: A rise in hydrogen (≥20 ppm within 90 minutes)  typically indicates SIBO.
  • Methane: A methane value of ≥10 ppm in your baseline sample or within 120 minutes of starting the test typically indicates IMO [37]. 

Challenges of breath testing

Breath testing, while widely used, has a few limitations: 

  • False Positives: Sugars moving too quickly to the large intestine can trigger misleading results.
  • False Negatives: Slow digestion or low bacterial activity may fail to show overgrowth.
  • Accuracy Issues: Factors like gut transit time or improper preparation can affect results [38], [32].

This said, breath testing remains the most practical and widely available tool for diagnosing SIBO and IMO, an important first step toward healing.

Duodenal aspirate culture

Another form of test for SIBO or IMO is a duodenal aspirate culture. During an upper endoscopy, a health practitioner directly samples fluid from your small intestine to check for bacterial overgrowth [39]. While this test is considered more accurate than a breath test, it’s invasive and rarely used in routine practice.

New diagnostic tools 

Researchers are developing new swallowable capsule technology to improve SIBO testing [40]. One type of capsule measures hydrogen and carbon dioxide levels in the body after eating carbohydrates, offering a more accurate alternative to breath tests. Another type collects bacteria directly from the small intestine, providing a clearer and more precise evaluation of SIBO. 

These advancements may enhance the accuracy and reliability of SIBO diagnosis in the future, paving the way for more effective treatments.

Managing SIBO: Approaches to healing

If you’re struggling with gut issues, understanding what’s causing the imbalance is essential. Food sensitivities, certain medications, and lifestyle habits could all be contributing factors. Let’s start by discussing how SIBO is typically treated, followed by strategies you can take to get to the root cause and support your gut health long-term.

Antibiotic therapy for SIBO

Oral antibiotics are a key for SIBO treatment [41]. The goal of antibiotics is not to completely eliminate bacteria but to reduce and balance them in the small intestine to relieve symptoms.

Several antibiotics, including amoxicillin with clavulanic acid, ciprofloxacin, doxycycline, and metronidazole, have been studied for SIBO treatment [42]. However, repeated antibiotic use carries risks of antibiotic resistance, recurrence, gut imbalances, and infections like Clostridium difficile

Rifaximin has emerged as a preferred treatment option for SIBO due to its benefits:

  • Studies show that rifaximin successfully resolves SIBO in 71% of cases [43].
  • Unlike other antibiotics, rifaximin acts like a eubiotic, targeting specific microbes while supporting beneficial bacteria like Lactobacillus and Bifidobacterium [44]. 
  • Rifaximin doesn’t lead to bacterial resistance, making it suitable for repeat use [45]. 

Testing your gut microbiome 

When managing SIBO, a good place to start is addressing its root cause. An Adult Gut Health Test gives a holistic picture of your gut microbiome and may identify imbalances contributing to your SIBO or other gut issues. Your Gut Health Report provides deep insights, such as:

  • Gut diversity: A diverse range of gut bacteria is a sign of better overall health, as more of the right species support a stronger, more balanced microbiome.
  • Beneficial bacteria: Identifying bacteria that help boost metabolism and fight inflammation, which is key to gut and overall wellness.
  • Disruptive microbes: It can also identify potential problems, like unfriendly pathogens or bacteria that degrade the gut’s protective mucus layer.

Every Tiny Health test comes with a personalized Action Plan with recommendations for diet, supplements, and lifestyle changes to help re-balance your disrupted gut. A coaching session with a microbiome specialist helps you navigate the results and your next steps, keeping in mind the symptoms you’re experiencing.

Dietary approaches to manage SIBO

What you eat directly impacts bacterial growth and fermentation in your gut. By carefully choosing foods, you can reduce symptoms like bloating, gas, and discomfort while healing your gut over several months. Let’s explore some key approaches for managing SIBO through diet.

Low-FODMAP diet

FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. This diet eliminates fermentable carbs like fructose, lactose, and sugar alcohols, which feed bacteria in the small intestine [46]. By limiting these, gas production and bloating are significantly reduced.

Choosing prebiotic foods wisely

Prebiotic foods nourish beneficial bacteria, but for people with SIBO, certain prebiotics can worsen symptoms by overfeeding bacteria in the small intestine. Careful moderation is key.

These SIBO-friendly prebiotic foods offer nutrients and support gut health without excessive fermentation:

  • Green bananas and plantains contain resistant starch that feeds good bacteria without causing gas [47].
  • Unripe papaya provides digestive enzymes and minimal fermentable fibers [48].
  • Kiwi offers fiber and enzymes, often well-tolerated in small amounts [49].
  • Zucchini, cucumbers (seedless), and carrots are sources of soluble fiber that are less likely to cause bloating [50].
  • Flaxseeds are rich in omega-3 fatty acids and soluble fiber, which support the gut lining without overfeeding bacteria [51].

Avoid high-FODMAP foods and those rich in insoluble fiber, which can worsen SIBO symptoms, including:

  • Onions and garlic (especially raw or whole).
  • Asparagus, artichokes, and brussels sprouts.
  • Legumes like lentils and chickpeas.
  • Fruits such as apples, pears, and watermelon.

Elemental diet

The elemental diet is a liquid diet containing pre-digested nutrients that “starves” harmful bacteria while still providing essential nutrition. It’s often used short-term for severe cases to offer quick symptom relief [52].

Bi-phasic diet

The bi-phasic diet is a phased approach that starts by strictly reducing bacterial fuel and gradually reintroducing foods to assess tolerance [53]. Eating smaller, well-spaced meals also supports digestion and improves gut motility.

Fiber management 

Not all fiber is created equal. Soluble fiber dissolves in water, forming a gel-like substance that’s gentler on digestion. Insoluble fiber adds bulk to stool but can worsen fermentation and symptoms in SIBO.

Tailoring fiber intake to your needs is important [54]—some may benefit from reducing fiber, while others may tolerate specific types that don’t trigger gas.

By focusing on foods that are easier to digest and being mindful of potential triggers, you can better manage SIBO symptoms and work toward a healthier, balanced gut.

Supplements for SIBO

Finding the right supplements can help you address deficiencies, support digestion, and promote gut healing. Here are some supplements your practitioner may recommend:

  • Digestive enzymes help with proper food breakdown, especially if pancreatic enzyme production is low [55].
  • Probiotics like Lactobacillus and Bifidobacterium may help support gut balance [56].
  • Peppermint oil and ginger can help improve gut motility and reduce discomfort [57],[58].
  • Gut-healing nutrients like L-glutamine and zinc support the repair of the stomach and intestine lining and help reduce inflammation [59],[60].

Take control of your digestive health

SIBO can really take a toll on your daily life, but understanding it is the first step to finding healing. It’s important to talk with a health practitioner if you are experiencing ongoing symptoms so you can find the right SIBO test and treatment plan. 

Take control of your digestive health and get to the root cause of symptoms like bloating, gas, and constipation. Discover a science-backed approach to long-lasting relief with a Tiny+ membership, which includes a gut health test to establish your baseline, a coaching session with a microbiome specialist, and a follow-up gut health test to track your progress. This is your sign to take action, get to know your gut microbiome, and make changes to your diet and lifestyle to help soothe your gut, helping you get back to feeling like yourself again.

A Tiny Health Gut Health Test showing a gut health report on a phone app and printed PDF report

Trust your gut.

Get to know your microbes with an easy, 5-minute at-home test from Tiny Health. Unlock deep gut health insights and personalized recommendations for your diet, supplements, and lifestyle.

References

[1] R. Sender, S. Fuchs, and R. Milo, “Revised Estimates for the Number of Human and Bacteria Cells in the Body,” PLOS Biology, vol. 14, no. 8, p. e1002533, Aug. 2016, doi: https://doi.org/10.1371/journal.pbio.1002533

[2] A. C. Dukowicz, B. E. Lacy, and G. M. Levine, “Small intestinal bacterial overgrowth: a comprehensive review,” Gastroenterology & Hepatology, vol. 3, no. 2, pp. 112–122, Feb. 2007, Available: https://pubmed.ncbi.nlm.nih.gov/21960820/

[3] A. H. Sachdev and M. Pimentel, “Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance,” Therapeutic Advances in Chronic Disease, vol. 4, no. 5, pp. 223–231, Jul. 2013, doi: https://doi.org/10.1177/2040622313496126

[4] D. Poon, G. R. Law, G. Major, and H. J. N. Andreyev, “A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome,” Scientific Reports, vol. 12, no. 1, Feb. 2022, doi: https://doi.org/10.1038/s41598-022-05933-1

[5] A. Gandhi et al., “Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis,” Gut Microbes, vol. 13, no. 1, p. 1933313, Jan. 2021, doi: https://doi.org/10.1080/19490976.2021.1933313

[6] M. Banaszak, I. Górna, D. Woźniak, J. Przysławski, and S. Drzymała-Czyż, “Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO,” Microorganisms, vol. 11, no. 3, p. 573, Feb. 2023, doi: https://doi.org/10.3390/microorganisms11030573

[7] S. J. Sorathia and J. M. Rivas, “Small Intestinal Bacterial Overgrowth,” PubMed, 2020. Available: https://www.ncbi.nlm.nih.gov/books/NBK546634/

[8] A. K. R. Reddivari and P. Mehta, “Gastroparesis,” PubMed, 2020. Available: https://www.ncbi.nlm.nih.gov/books/NBK551528/

[9] R. Castro, “Diabetes Drugs and Weight Loss,” Mayo Clinic, Jun. 29, 2022. Available: https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955

[10] International Foundation for Gastrointestinal Disorders, “Opioid Induced Constipation,” IFFGD. Available: https://iffgd.org/gi-disorders/opioid-induced-constipation/

[11] “Anticholinergic Agents,” PubMed, 2012. Available: https://pubmed.ncbi.nlm.nih.gov/31643610/

[12] S.-X. Wang, “Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice,” World Journal of Gastroenterology, vol. 11, no. 13, p. 2016, 2005, doi: https://doi.org/10.3748/wjg.v11.i13.2016

[13] J. Kossewska, K. Bierlit, and V. Trajkovski, “Personality, Anxiety, and Stress in Patients with Small Intestine Bacterial Overgrowth Syndrome. The Polish Preliminary Study,” International Journal of Environmental Research and Public Health, vol. 20, no. 1, p. 93, Dec. 2022, doi: https://doi.org/10.3390/ijerph20010093

[14] A. Tursi, G. Brandimarte, and G. Giorgetti, “High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal,” The American Journal of Gastroenterology, vol. 98, no. 4, pp. 839–843, Apr. 2003, doi: https://doi.org/10.1111/j.1572-0241.2003.07379.x

[15] F. Castiglione et al., “Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease,” Alimentary Pharmacology & Therapeutics, vol. 18, no. 11–12, pp. 1107–1112, Nov. 2003, doi: https://doi.org/10.1046/j.1365-2036.2003.01800.x

[16] X. Feng and X.-Q. Li, “The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis,” Aging, vol. 14, no. 2, pp. 975–988, Jan. 2022, doi: https://doi.org/10.18632/aging.203854

[17] A. Patil, “Link between hypothyroidism and small intestinal bacterial overgrowth,” Indian Journal of Endocrinology and Metabolism, vol. 18, no. 3, p. 307, 2014, doi: https://doi.org/10.4103/2230-8210.131155. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056127/

[18] U. C. Ghoshal, “Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype,” World Journal of Gastroenterology, vol. 20, no. 10, p. 2482, 2014, doi: https://doi.org/10.3748/wjg.v20.i10.2482

[19] A. Shah et al., “Small intestinal bacterial overgrowth in chronic liver disease: an updated systematic review and meta-analysis of case-control studies,” EClinicalMedicine, vol. 80, pp. 103024–103024, Dec. 2024, doi: https://doi.org/10.1016/j.eclinm.2024.103024. Available: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00603-5/fulltext. [Accessed: Jan. 22, 2025]

[20] B. C. Roland et al., “Obesity increases the risk of small intestinal bacterial overgrowth (SIBO),” Neurogastroenterology & Motility, vol. 30, no. 3, p. e13199, Sep. 2017, doi: https://doi.org/10.1111/nmo.13199

[21] A. Therrien, S. Bouchard, S. Sidani, and M. Bouin, “Prevalence of Small Intestinal Bacterial Overgrowth among Chronic Pancreatitis Patients: A Case-Control Study,” Canadian Journal of Gastroenterology and Hepatology, vol. 2016, pp. 1–7, 2016, doi: https://doi.org/10.1155/2016/7424831

[22] K. Morrisroe, M. Baron, T. Frech, and M. Nikpour, “Small intestinal bacterial overgrowth in systemic sclerosis,” Journal of Scleroderma and Related Disorders, vol. 5, no. 1, pp. 33–39, Jul. 2019, doi: https://doi.org/10.1177/2397198319863953

[23] R. R. Kedika, R. F. Souza, and S. J. Spechler, “Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications,” Digestive diseases and sciences, vol. 54, no. 11, pp. 2312–2317, Nov. 2009, doi: https://doi.org/10.1007/s10620-009-0951-9. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035917/. [Accessed: Dec. 28, 2020]

[24] L. Liao, B.-B. Su, and S.-P. Xu, “Helicobacter pylori infection and small intestinal bacterial overgrowth: a systematic review and meta-analysis,” BMC Microbiology, vol. 23, no. 1, Dec. 2023, doi: https://doi.org/10.1186/s12866-023-03063-w

[25] Fidele Kakule Kitaghenda, H. Jiang, Y. Shao, L. Yao, and X. Zhu, “The Prevalence of Small Intestinal Bacterial Overgrowth After Roux-en-Y Gastric Bypass (RYGB): a Systematic Review and Meta-analysis,” Obesity Surgery, Dec. 2023, doi: https://doi.org/10.1007/s11695-023-06974-9

[26] Cleveland Clinic, “SIBO (Small Intestinal Bacterial Overgrowth): Symptoms, Diet, Causes & What it Is,” Cleveland Clinic, Sep. 19, 2021. Available: https://my.clevelandclinic.org/health/diseases/21820-small-intestinal-bacterial-overgrowth-sibo

[27] Y. El-Hakim, S. Bake, K. K. Mani, and F. Sohrabji, “Impact of intestinal disorders on central and peripheral nervous system diseases,” Neurobiology of Disease, vol. 165, p. 105627, Apr. 2022, doi: https://doi.org/10.1016/j.nbd.2022.105627

[28] S. S. C. Rao, A. Rehman, S. Yu, and N. M. de Andino, “Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis,” Clinical and Translational Gastroenterology, vol. 9, no. 6, Jun. 2018, doi: https://doi.org/10.1038/s41424-018-0030-7. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006167/

[29] W. P. Bowe and A. C. Logan, “Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?,” Gut Pathogens, vol. 3, no. 1, p. 1, 2011, doi: https://doi.org/10.1186/1757-4749-3-1. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038963/

[30] H. Daou, M. Paradiso, K. Hennessy, and L. Seminario-Vidal, “Rosacea and the Microbiome: A Systematic Review,” Dermatology and Therapy, vol. 11, no. 1, pp. 1–12, Nov. 2020, doi: https://doi.org/10.1007/s13555-020-00460-1

[31] F. Drago, G. Ciccarese, E. Indemini, V. Savarino, and A. Parodi, “Psoriasis and small intestine bacterial overgrowth,” International Journal of Dermatology, vol. 57, no. 1, pp. 112–113, Oct. 2017, doi: https://doi.org/10.1111/ijd.13797

[32] J. Lim and A. Rezaie, “Pros and Cons of Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth,” Gastroenterology & Hepatology, vol. 19, no. 3, pp. 140–146, Mar. 2023, Available: https://pubmed.ncbi.nlm.nih.gov/37706108/

[33] A. Tansel and D. J. Levinthal, “UNDERSTANDING OUR TESTS: HYDROGEN-METHANE BREATH TESTING TO DIAGNOSE SMALL INTESTINAL BACTERIAL OVERGROWTH,” Clinical and Translational Gastroenterology, vol. 14, no. 4, Feb. 2023, doi: https://doi.org/10.14309/ctg.0000000000000567. Available: https://pubmed.ncbi.nlm.nih.gov/36744854/

[34] U. C. Ghoshal, “How to Interpret Hydrogen Breath Tests,” Journal of Neurogastroenterology and Motility, vol. 17, no. 3, pp. 312–317, Jul. 2011, doi: https://doi.org/10.5056/jnm.2011.17.3.312. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155069/

[35] Cleveland Clinic, “Hydrogen Breath Test: What Is It, How to Prep & Results,” Cleveland Clinic, May 03, 2022. Available: https://my.clevelandclinic.org/health/diagnostics/12360-hydrogen-breath-test

[36] N. Mattio et al., “Glucose breath test for the detection of small intestine bacterial overgrowth: Impact of diet prior to the test,” Neurogastroenterology & Motility, vol. 36, no. 6, Apr. 2024, doi: https://doi.org/10.1111/nmo.14801

[37] A. Rezaie et al., “Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus,” The American Journal of Gastroenterology, vol. 112, no. 5, pp. 775–784, May 2017, doi: https://doi.org/10.1038/ajg.2017.46. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418558/

[38] M. Bohm, R. M. Siwiec, and J. M. Wo, “Diagnosis and Management of Small Intestinal Bacterial Overgrowth,” Nutrition in Clinical Practice, vol. 28, no. 3, pp. 289–299, Apr. 2013, doi: https://doi.org/10.1177/0884533613485882

[39] Y. Maeda and T. Murakami, “Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth,” Antibiotics, vol. 12, no. 2, p. 263, Feb. 2023, doi: https://doi.org/10.3390/antibiotics12020263. Available: https://www.mdpi.com/2079-6382/12/2/263

[40] M. Pimentel, R. J. Saad, M. D. Long, and S. S. C. Rao, “ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth,” The American Journal of Gastroenterology, vol. 115, no. 2, pp. 165–178, Feb. 2020, doi: https://doi.org/10.14309/ajg.0000000000000501

[41] B. Skrzydło-Radomańska and B. Cukrowska, “How to Recognize and Treat Small Intestinal Bacterial Overgrowth?,” Journal of Clinical Medicine, vol. 11, no. 20, p. 6017, Jan. 2022, doi: https://doi.org/10.3390/jcm11206017. Available: https://www.mdpi.com/2077-0383/11/20/6017/htm

[42] E. M. M. Quigley, J. A. Murray, and M. Pimentel, “AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review,” Gastroenterology, vol. 159, no. 4, pp. 1526–1532, Oct. 2020, doi: https://doi.org/10.1053/j.gastro.2020.06.090

[43] J. Wang, L. Zhang, and X. Hou, “Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis,” Expert Review of Gastroenterology & Hepatology, vol. 15, no. 12, pp. 1385–1399, Nov. 2021, doi: https://doi.org/10.1080/17474124.2021.2005579

[44] F. R. Ponziani, M. A. Zocco, F. D’Aversa, M. Pompili, and A. Gasbarrini, “Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation,” World Journal of Gastroenterology, vol. 23, no. 25, p. 4491, 2017, doi: https://doi.org/10.3748/wjg.v23.i25.4491

[45] M. Pimentel, B. D. Cash, A. Lembo, R. A. Wolf, R. J. Israel, and P. Schoenfeld, “Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity,” Digestive Diseases and Sciences, vol. 62, no. 9, pp. 2455–2463, Jun. 2017, doi: https://doi.org/10.1007/s10620-017-4598-7

[46] A. Thomas, A. Thomas, and M. Butler-Sanchez, “Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome,” American Journal of Lifestyle Medicine, vol. 16, no. 5, p. 155982762110129, May 2021, doi: https://doi.org/10.1177/15598276211012968

[47] Z. Chen et al., “Resistant starch and the gut microbiome: Exploring beneficial interactions and dietary impacts,” Food Chemistry: X, vol. 21, p. 101118, Mar. 2024, doi: https://doi.org/10.1016/j.fochx.2024.101118. Available: https://www.sciencedirect.com/science/article/pii/S2590157524000051

[48] M. Leitão, T. Ribeiro, P. A. García, L. Barreiros, and P. Correia, “Benefits of Fermented Papaya in Human Health,” Foods, vol. 11, no. 4, p. 563, Feb. 2022, doi: https://doi.org/10.3390/foods11040563

[49] L. Drummond and R. B. Gearry, “Kiwifruit modulation of gastrointestinal motility,” Advances in Food and Nutrition Research, vol. 68, pp. 219–232, 2013, doi: https://doi.org/10.1016/B978-0-12-394294-4.00012-2. Available: https://pubmed.ncbi.nlm.nih.gov/23394990/#:~:text=Constipation%20results%20from%20gastrointestinal%20dysmotility. [Accessed: May 18, 2022]

[50] K. Syed and K. Iswara, “Low-FODMAP Diet,” PubMed, 2021. Available: https://www.ncbi.nlm.nih.gov/books/NBK562224/

[51] K. Kleigrewe et al., “Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations,” International Journal of Molecular Sciences, vol. 23, no. 18, p. 10473, Sep. 2022, doi: https://doi.org/10.3390/ijms231810473

[52] A. S. Akers, “Can the elemental diet reduce SIBO symptoms?,” Medicalnewstoday.com, May 17, 2023. Available: https://www.medicalnewstoday.com/articles/elemental-diet-sibo

[53] N. Jacobi, “The SIBO Bi-Phasic Diet,” AIM Cancer Center, 2018. Available: https://aim.clinic/wp-content/uploads/2024/02/bi-phasicdietprotocol_121018-sibo-fodmap.pdf

[54] C.-B. Ioniță-Mîndrican et al., “Therapeutic Benefits and Dietary Restrictions of Fiber Intake: A State of the Art Review,” Nutrients, vol. 14, no. 13, p. 2641, Jun. 2022, doi: https://doi.org/10.3390/nu14132641. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268622/

[55] M. Denhard, “Digestive Enzymes and Digestive Enzyme Supplements,” www.hopkinsmedicine.org, 2022. Available: https://www.hopkinsmedicine.org/health/wellness-and-prevention/digestive-enzymes-and-digestive-enzyme-supplements

[56] L. Redondo-Cuevas et al., “Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial,” Nutrients, vol. 16, no. 7, p. 1083, Jan. 2024, doi: https://doi.org/10.3390/nu16071083. Available: https://www.mdpi.com/2072-6643/16/7/1083

[57] NHS, “Peppermint oil: a medicine to treat to treat stomach cramps and bloating,” nhs.uk, Jul. 27, 2021. Available: https://www.nhs.uk/medicines/peppermint-oil/

[58] M.-L. Hu et al., “Effect of ginger on gastric motility and symptoms of functional dyspepsia,” World Journal of Gastroenterology, vol. 17, no. 1, pp. 105–110, Jan. 2011, doi: https://doi.org/10.3748/wjg.v17.i1.105. Available: https://www.ncbi.nlm.nih.gov/pubmed/21218090. [Accessed: Feb. 14, 2020]

[59] M.-H. Kim and H. Kim, “The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases,” International Journal of Molecular Sciences, vol. 18, no. 5, p. 1051, May 2017, doi: https://doi.org/10.3390/ijms18051051. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454963/

[60] A. S. Lee, J. Baker, Erik Jan Wamsteker, R. J. Saad, and M. J. DiMagno, “Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use,” PubMed, vol. 114, no. 7, pp. 1163–1171, Jul. 2019, doi: https://doi.org/10.14309/ajg.0000000000000200. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610753/